Publications by authors named "M Uchida"
Over-drainage after a ventriculoperitoneal (VP) shunt can often lead to chronic subdural hematoma; however, the treatment is unclear. Hematoma drainage is performed after physically stopping the shunt function, such as by ligating or removing the shunt system. However, shunt reconstruction is required after the subdural hematoma improves.
View Article and Find Full Text PDFArticle Synopsis
- The study emphasizes the significance of nickel, copper, and selenium as essential biometals in various industries, but highlights their harmful impact as environmental pollutants when they exceed normal levels, particularly in aquatic ecosystems.
- Research on medaka fish embryos revealed that exposure to these biometals led to significant developmental abnormalities and increased mortality rates throughout a 14-day observation period.
- Gene expression analysis showed that copper was the most toxic, affecting over 4,700 genes, while all three biometals caused detrimental effects on fish embryo development, underscoring the necessity of monitoring biometal levels to protect aquatic life.
Introduction: Multicenter research initiatives in Brazilian dialysis centers are scarce. We described the recruitment and implementation phases of the SARC-HD study, aimed at investigating sarcopenia and its impact on adverse clinical outcomes.
Methods: The SARC-HD is a cohort study being conducted with patients on hemodialysis in Brazil.
Mild cognitive impairment (MCI) refers to cognitive alterations with preservation of functionality. Individuals with this diagnosis have a higher risk of developing dementia. Non-pharmacological interventions, such as physical exercise, are beneficial for the cognition of this population.
View Article and Find Full Text PDFBackground/aim: Despite the seriousness of lung adverse events (AEs) associated with lenvatinib, comprehensive data on these events remain limited. This study was conducted to examine the disproportionality, time to onset, incidence rates, and outcomes of lenvatinib-associated lung AEs using the Japanese Adverse Drug Event Report database.
Patients And Methods: We analysed data for the period from April 2004 to May 2023.